U.S. In Vitro Diagnostics Market Size & Outlook, 2026-2033
The in vitro diagnostics market in the United States is expected to reach a projected revenue of US$ 65,017.9 million by 2033. A compound annual growth rate of 4.8% is expected of the United States in vitro diagnostics market from 2026 to 2033.
U.S. in vitro diagnostics market outlook highlights
The U.S. in vitro diagnostics market outlook generated a revenue of USD 44,828.3 million in 2025 and is expected to reach USD 65,017.9 million by 2033.
The market is expected to grow at a CAGR of 4.8% from 2026 to 2033.
In terms of segment, immunodiagnostics was the largest revenue generating technology in 2025.
Molecular Diagnostics is the most lucrative technology segment registering the fastest growth during the forecast period.
In Vitro Diagnostics Market Outlook data book summary
Market revenue in 2025
USD 44,828.3 million
Market revenue in 2033
USD 65,017.9 million
Growth rate
4.8% (CAGR from 2026 to 2033)
Largest segment
Immunodiagnostics
Fastest growing segment
Molecular Diagnostics
Historical data
2021 - 2024
Base year
2025
Forecast period
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Hematology, Coagulation & Hemostasis, Clinical Microbiology, Blood Glucose Testing, Urinalysis, Blood Gas And Critical Care Testing, Clinical Chromatography And Mass Spectrometry, Other Technologies
Key market players worldwide
Abbott, Bio-Rad Laboratories, Inc., Siemens Healthineers Ag Adr, Pbd Biotech, Qiagen Nv, Quidel Corporation, F. Hoffmann-La Roche Ltd., Danaher Corp, Quest Diagnostics Incorporated, Agilent Technologies, Inc., Biomerieux Sa
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to In Vitro Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Immunodiagnostics was the largest segment with a revenue share of 26.74% in 2025.
Horizon Databook has segmented the U.S. in vitro diagnostics market based on immunodiagnostics, clinical chemistry, molecular diagnostics, hematology, coagulation & hemostasis, clinical microbiology, blood glucose testing, urinalysis, blood gas and critical care testing, clinical chromatography and mass spectrometry, other technologies covering the revenue growth of each sub-segment from 2021 to 2033.
U.S. In Vitro Diagnostics Market Technology Outlook (Revenue, USD Million , 2021-2033)
Immunodiagnostics
Clinical Chemistry
Molecular Diagnostics
Hematology
Coagulation & Hemostasis
Clinical Microbiology
Blood Glucose Testing
Urinalysis
Blood Gas and Critical Care Testing
Clinical Chromatography and Mass Spectrometry
Other Technologies
U.S. In Vitro Diagnostics Market Product Outlook (Revenue, USD Million , 2021-2033)
Instruments
Reagents, Kits & Consumables
Software & Services
U.S. In Vitro Diagnostics Market Specimen Outlook (Revenue, USD Million , 2021-2033)
Whole Blood
Serum
Plasma
Urine
Tissue and Biopsy Specimens
Swab Specimens
Saliva and Oral Fluid
Stool
Cerebrospinal Fluid
Other Human Derived Specimens
U.S. In Vitro Diagnostics Market Application Outlook (Revenue, USD Million , 2021-2033)
Infectious Diseases
Oncology
Cardiovascular Diseases
Diabetes, Endocrine, Bone and Mineral Disorders
Autoimmune and Inflammatory Diseases
Kidney Diseases
Hematologic and Coagulation Disorders
Genetic and Inherited Disorders
Women’s Health, Reproductive and Prenatal Diagnostics
Blood Screening and Transfusion Diagnostics
Allergy Diagnostics
Therapeutic Drug Monitoring and Clinical Toxicology
General Health Screening and Routine Testing
Other Clinical Applications
U.S. In Vitro Diagnostics Market End Use Outlook (Revenue, USD Million , 2021-2033)
Hospital Clinics
Clinical Laboratories
Blood Banks and Transfusion Centres
Home Care Settings
Other End User
Reasons to subscribe to In Vitro Diagnostics Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of In Vitro Diagnostics Market Outlook databook
Our clientele includes a mix of In Vitro Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. In Vitro Diagnostics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.S. In Vitro Diagnostics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
U.S. In Vitro Diagnostics Market, 2021-2033 (US$M)